Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft

NCT02878694 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT02878694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02878694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft
Lead sponsor
University Hospital, Caen
Phase
Phase 2/3
Overall status
Terminated
Start date
November 14, 2019
Completion date
October 9, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscular dystrophy, oculopharyngeal, ptosis